Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 543308 | NSE Symbol : KIMS | ISIN : INE967H01025 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
02-May-2025	12-May-2025	Accounts	Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve Board Meeting Intimation Outcome of Board Meeting (As Per BSE Announcement Dated on: 12/05/2025)
27-Jan-2025	06-Feb-2025	Quarterly Results	Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 inter alia to consider and approve we hereby inform you that a meeting of the Board of Directors of Krishna Institute of Medical Sciences Limited is scheduled to be held on Thursday February 06 2025 inter alia to consider and approve the unaudited (Standalone & Consolidated) financial results of the company for the 03rd quarter and nine months ended December 31 2024. Outcome of the Board Meeting Quarterly Results_31st December, 2024 (As per BSE Announcement Dated on 06/02/2025)
04-Jan-2025	04-Jan-2025	Change in Directors	Appointment of New Independent Director
25-Oct-2024	09-Nov-2024	Quarterly Results	Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 inter alia to consider and approve the un-audited (Standalone & Consolidated) financial results of the Company for the 02nd quarter and half-year ended September 30 2024. Half-year ended 30 September 2024 together with the Limited Review Reports as reviewed by the Audit Committee. (As Per BSE Announcement dated on 09.11.2024)
25-Jul-2024	07-Aug-2024	Quarterly Results	Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve the unaudited (Standalone & Consolidated) financial results of the company for the 01st quarter ended June 30 2024. Financial Results for the 01st Quarter ended 30th June 2024. Outcome of the Board Meeting held on 07th August 2024. (As per BSE Announcement Dated on 07/08/2024)
24-Jun-2024	28-Jun-2024	Stock Split	Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/06/2024 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Friday June 28th 2024 to consider the following items: a) Sub-division/split of existing 1 (One) Equity Share of the face value of Rs. 10/- (Rupees Ten Only) each fully paid up into 5 (Five) Equity Shares of the face value of Rs. 2/- (Rupees Two Only) each fully paid up. b) Reclassification of the persons from the Promoter Group Category to the Public Category. The Board approved Re-classification of persons falling under Promoter Group and Sub-division/Stock Split of equity shares of the Company Approval of Board of Directors for Re-classification of Promoter Group to Public Category. (As Per BSE Announcement Dated on: 28/06/2024)
02-May-2024	16-May-2024	Accounts	Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 inter alia to consider and approve the audited (Standalone & Consolidated) financial results of the company for the quarter and financial year ended March 31 2024. Results- Financial Results for the FY ended 31.3.2024 Re- appointment of Statutory Auditors (As per BSE Announcement Dated on 16/05/2024)
23-Jan-2024	03-Feb-2024	Quarterly Results	Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2024 inter alia to consider and approve the un-audited (Standalone & Consolidated) financial results of the company for the quarter and nine months ended December 31 2023. Outcome of Board Meeting held on 3rd February, 2024 (As Per BSE Announcement Dated on: 03/02/2024)
28-Nov-2023	28-Nov-2023	Change in Directors	Outcome of Board Meeting held on 28th November 2023 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Intimation of Change of Directors pursuant to Regulation 30 of SEBI LODR.
30-Oct-2023	07-Nov-2023	Quarterly Results	Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve the un-audited (Standalone & Consolidated) financial results of the company for the quarter and half-year ended September 30 2023. Approval of unaudited Quarterly and financial results for the quarter and half yearly ended 30.09.2023. unaudited financial results for the quarter and Half Yearly ended 30.09.2023 Resignation of Mr. Shantanu Rastogi as Non-Executive & Non-Independent Director of the Company. (As Per BSE Announcement dated on 07.11.2023)
31-Jul-2023	07-Aug-2023	Quarterly Results	Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 inter alia to consider and approve meeting of the Board of Directors of Krishna Institute of Medical Sciences Limited is scheduled to be held on Monday August 7 2023 inter alia to consider and approve the Unaudited (Standalone & Consolidated) Financial results of the company for the 1st quarter ended June 30 2023. Further to our intimations dated 31st July 2023, the Board of Directors, at its meeting held today, has approved the Un-Audited (Standalone and Consolidated) Financial Results of the Company for the 01st Quarter ended 30th June 2023 together with Limited Review Reports which has been reviewed by the Audit Committee and approved by the Board of Directors. Dr. B. Bhaskara Rao, Promoter & CMD has intimated to the Board that he has acquired 64.36% of the equity stake in M/s. Som Datt Finance Corporation Ltd, (Listed NBFC) and has been inducted into its Board as a Director. 1. Approval of unaudited financial Results for the Quarter ended 30.06.2023. 2. Dr. B Bhaskara Rao has intimated the Board that he has acquired 64.36% of Equity stake in Som Datt Finance Corporation Limited and has been inducted into its Board as Director. (As per BSE Announcement Dated on 07/08/2023)
26-Jul-2023	26-Jul-2023	Change in Other Executives	Intimation of the Appointment of Mr. Sachin Ashok Salvi as Chief Financial Officer and KMP of the Company w.e.f August 01, 2023
11-May-2023	18-May-2023	Accounts	Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2023 inter alia to consider and approve the Audited (Standalone & Consolidated) Financial results of the company for the quarter and financial year ended March 31 2023. Audited Results & Quarterly Results (As Per BSE Bulletin dated on 11.05.2023) 1. Approval of Audited standalone & Consolidated financial results of the Company for the quarter and year ended 31st March 2023, along with the Audit Report on the Standalone & Consolidated Financial Statements. 2. Resignation of CFO Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors have approved the Audited Standalone and Consolidated Financial Results of the Company along with the Auditor's Report for the Quarter and Year ended 31st March 2023 issued by M/s. S.R. Batliboi & Associates LLP, the Statutory Auditors of the Company which are enclosed to this letter. The 21st Annual General Meeting of the Company will be held on Wednesday, 30th August 2023. (As per BSE Announcement Dated on 18/05/2023)
28-Jan-2023	09-Feb-2023	Quarterly Results	Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve the Un-Audited (Standalone & Consolidated) Financial results of the company for the 3rd quarter and nine months ended December 31 2022 Further to our intimations dated 28th January 2023, the Board of Directors, at its meeting held today, has approved the Un-Audited Standalone and Consolidated Financial Results of the Company for the 3rd Quarter and nine months ended 31st December 2022 together with Limited Review Reports which have been reviewed by the Audit Committee and approved by the Board of Directors. (As Per BSE Announcement Dated on 09/02/2023)
31-Dec-2022	04-Jan-2023	Issue of Debentures	Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/01/2023 inter alia to consider and approve A meeting of the Board of Directors of the Company is scheduled to be held on Wednesday January 4 2023 inter alia to consider and approve raising of funds by way of issuance of Non-Convertible Debentures (NCDs) aggregating to Rs. 300 Crores in one or more tranches over a period of time The Board of Directors, at its meeting held today, has inter alia, approved the raising of funds by way of issuance of Non-Convertible Debentures (NCDs) aggregating to Rs. 300 Crores in one or more tranches over a period of time, subject to shareholders approval. (As Per BSE Announcement Dated on 04.01.2023)

1 2

LOGIN HERE

Krishna Institute of Medical Sciences Ltd

Board Meeting